Cancer patients failed by latest breach of '62 day wait' target
Experts say that cancer patients are being failed as new figures show waiting time targets for treatment have been missed for the third consecutive quarter.
Nov 20, 2014
0
0
Archive: 20/11/2014
Virus discovery could impact HIV drug research
A research team led by Portland State University (PSU) biology professor Ken Stedman has unlocked the structure of an unusual virus that lives in volcanic hot springs. The discovery could pave the way for better drugs to ...
Nov 20, 2014
Protein mutation alters tissue development in males before birth
Case Western Reserve researchers have identified a protein mutation that alters specific gender-related tissue in males before birth and can contribute to the development of cancer as well as other less life-threatening challenges.
Nov 20, 2014
Elite athletes under stress to lose weight
Psychology researchers at the University of Adelaide say modern day elite athletes are under so much pressure to lose and maintain weight that they can also lose a sense of self.
Nov 20, 2014
Vaccine against Chikungunya successful in phase 1
The induction of neutralizing antibodies by a prophylactic Chikungunya vaccine candidate has now been confirmed by the final results of a phase 1 clinical trial, as well as its tolerability and safety. Detailed information ...
Nov 20, 2014
Gene therapy provides safe, long-term relief for patients with severe hemophilia B
(Medical Xpress)—Gene therapy developed at St. Jude Children's Research Hospital, University College London (UCL) and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing ...
Nov 20, 2014
New approach for treating ALS
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that primarily kills motor neurons, leading to paralysis and death 2 to 5 years from diagnosis. Currently ALS has no ...
Nov 20, 2014
